Atyr Pharma Inc (ATYR)

05:58 AM

Atyr Pharma: Fourth Quarter Earnings Overview - Bitget

05:58 AM

04:49 AM

aTyr Pharma (NASDAQ:ATYR) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

04:49 AM

04:42 AM

aTyr (ATYR) Achieves Milestone with Phase 3 Study Results - GuruFocus

04:42 AM

04:11 AM

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update - The Manila Times

04:11 AM

04:11 AM

Atyr Pharma: Q4 Earnings Snapshot - marketscreener.com

04:11 AM

Mar 04, 2026

ATYR Financials: Income Statement, Balance Sheet & Cash Flow | Atyr Pharma Inc - Stock Titan

Mar 04, 2026

Feb 28, 2026

ATYR PE Ratio & Valuation, Is ATYR Overvalued - Intellectia AI

Feb 28, 2026

Feb 28, 2026

aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Feb 28, 2026

Feb 27, 2026

aTyr Pharma Faces Pivotal Regulatory and Financial Milestones - AD HOC NEWS

Feb 27, 2026

Feb 26, 2026

aTyr Pharma (ATYR) Stock Analysis: Exploring a Potential 327% Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 26, 2026

Feb 25, 2026

aTyr Pharma Q4 2025 Earnings Call Transcript - MarketBeat

Feb 25, 2026

Feb 25, 2026

aTyr Pharma (NASDAQ:ATYR) Trading Down 2.1%Should You Sell? - MarketBeat

Feb 25, 2026

Feb 20, 2026

ATyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Feb 20, 2026

Feb 20, 2026

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Feb 20, 2026

Feb 20, 2026

aTyr Pharma, Inc. (ATYR) Stock Analysis: Unveiling a Potential 338% Upside in the Biotechnology Arena - DirectorsTalk Interviews

Feb 20, 2026

Feb 18, 2026

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference - Bitget

Feb 18, 2026

Feb 18, 2026

aTyr Pharma Insiders Added US$926.8k Of Stock To Their Holdings - simplywall.st

Feb 18, 2026

Feb 18, 2026

ATyr Pharma to Present at the Leerink Partners Global Healthcare Conference - marketscreener.com

Feb 18, 2026

Feb 16, 2026

Sentiment Recap: Does aTyr Pharma Inc stock benefit from AI growth2025 Volatility Report & AI Forecast Swing Trade Picks - baoquankhu1.vn

Feb 16, 2026

Feb 15, 2026

Levels Update: Will CompoSecure Inc Equity Warrant stock go up in YEARVolume Spike & Low Volatility Stock Recommendations - baoquankhu1.vn

Feb 15, 2026

Feb 15, 2026

The Truth About aTyr Pharma Inc (LIFE): Tiny Stock, Huge Bets – But Is It Worth the Hype? - AD HOC NEWS

Feb 15, 2026

Feb 14, 2026

Is aTyr Pharma Inc. stock cheap compared to fundamentalsQuarterly Risk Review & Verified Swing Trading Watchlist - mfd.ru

Feb 14, 2026

Feb 14, 2026

Is aTyr Pharma Inc. backed by strong institutional buyingWeekly Trend Report & Smart Investment Allocation Tips - mfd.ru

Feb 14, 2026

Feb 14, 2026

Why hedge funds are buying aTyr Pharma Inc. stock2025 EndofYear Setup & Risk Managed Investment Entry Signals - mfd.ru

Feb 14, 2026

Feb 13, 2026

Why analysts upgrade aTyr Pharma Inc. stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - mfd.ru

Feb 13, 2026

Feb 13, 2026

Facioscapulohumeral Muscular Dystrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Dyne Therapeutics, miRecule, Avidity Biosciences, aTyr Pharma, Fulcrum Therapeutics - Barchart.com

Feb 13, 2026

Feb 13, 2026

Facioscapulohumeral Muscular Dystrophy Market: High-Growth - openPR.com

Feb 13, 2026

Feb 13, 2026

Is aTyr Pharma Inc. stock resilient to inflationJuly 2025 Market Mood & High Accuracy Trade Alerts - mfd.ru

Feb 13, 2026

Feb 06, 2026

Weekly Buzz: ATYR To Meet With FDA, SGMO Aces Fabry Study, AQST's Anaphylm Gets Rejected - RTTNews

Feb 06, 2026

Feb 06, 2026

Aug Summary: Does aTyr Pharma Inc have pricing powerJuly 2025 Reactions & Community Consensus Trade Signals - baoquankhu1.vn

Feb 06, 2026

Feb 05, 2026

Market Outlook: Does aTyr Pharma Inc have pricing powerJuly 2025 Pullbacks & High Conviction Investment Ideas - baoquankhu1.vn

Feb 05, 2026

Feb 05, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: aTyr Pharma (ATYR), Pfizer (PFE) and Bicycle Therapeutics (BCYC) - The Globe and Mail

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CFO Broadfoot sells $1.5k in stock - Investing.com

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CEO Shukla sells $3.6k in stock By Investing.com - Investing.com Nigeria

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CEO Shukla sells $3.6k in stock - Investing.com UK

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CFO Broadfoot sells $1.5k in stock By Investing.com - Investing.com South Africa

Feb 05, 2026

Feb 04, 2026

aTyr Pharma general counsel sells $1091 in stock By Investing.com - Investing.com UK

Feb 04, 2026

Feb 04, 2026

aTyr Pharma general counsel sells $1091 in stock - Investing.com

Feb 04, 2026

Feb 03, 2026

FDA to review aTyr Pharma’s efzofitimod data in mid-April meeting - Investing.com Nigeria

Feb 03, 2026

Feb 03, 2026

aTyr Pharma gets FDA meeting on lead drug (ATYR:NASDAQ) - Seeking Alpha

Feb 03, 2026

Feb 03, 2026

Atyr Pharma announces scheduling of FDA type C meeting to discuss efzofitimod program in pulmonary sarcoidosis - marketscreener.com

Feb 03, 2026

Feb 03, 2026

aTyr Pharma (ATYR) Prepares for Key FDA Meeting on Efzofitimod - GuruFocus

Feb 03, 2026

Feb 03, 2026

aTyr Pharma Schedules FDA Meeting to Discuss Phase 3 EFZO-FIT™ Study Results for Efzofitimod in Pulmonary Sarcoidosis - Quiver Quantitative

Feb 03, 2026

Feb 03, 2026

ATyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis - marketscreener.com

Feb 03, 2026

Feb 03, 2026

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis - GlobeNewswire

Feb 03, 2026